Kagoshima, Japan

Nagata Ryoichi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Translational Research, Ltd.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nagata Ryoichi. Retrieved from https://idiyas.com/inventor/nagata-ryoichi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nagata Ryoichi

Introduction

Nagata Ryoichi is a notable inventor based in Kagoshima, Japan. He has made significant contributions to the field of diabetes treatment through his innovative work in insulin formulations. His dedication to improving healthcare solutions has led to the development of a unique patent that addresses the needs of diabetic patients.

Latest Patents

Nagata Ryoichi holds a patent for "Pernasally absorbable insulin preparations." This innovative insulin formulation utilizes porous, spherical calcium carbonate composed of trabeculate or needle-shaped crystals. The formulation serves as a carrier for insulin, providing a beneficial method for the treatment of diabetes. This advancement represents a significant step forward in diabetes management.

Career Highlights

Throughout his career, Nagata has been associated with Translational Research, Ltd., where he has focused on developing cutting-edge medical solutions. His work has been instrumental in bridging the gap between research and practical applications in the healthcare sector. His commitment to innovation has earned him recognition in the scientific community.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Nagata Ryoichi's contributions to the field of diabetes treatment through his innovative insulin formulation highlight the importance of research and development in healthcare. His work continues to inspire advancements that can improve the quality of life for many individuals living with diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…